NCT03351686View on ClinicalTrials.gov

Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

April 15, 2017

Study Completion Date

April 15, 2017

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Tranexamic Acid

Tranexamic acid (Kepron, Amoun, Egypt) was given slowly intravenously over 10 minutes just before the skin incision of elective cesarean section to group A. Tranexamic acid injection was prepared by diluting 1g (10 mL) tranexamic acid into 20 ml of 5% glucose.

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03351686 - Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section | Biotech Hunter | Biotech Hunter